The company maintains a vulnerable capital structure with a Debt/Equity ratio of 2.55 and a substantial $30.8B goodwill balance that may be susceptible to future impairment.
| Total Current Assets | 90.83B | 101.4B | 106.02B | 78.6B | 79.39B | 83.91B | 60.54B | 41.92B | 36.9B | 36.11B | 33.92B | 49.81B | 37.54B |
| Cash & Short-Term Investments | 17.8B | 25.98B | 34.76B | 22.12B | 13.18B | 23.24B | 19.68B | 10.03B | 8.94B | 11.74B | 9.36B | 18.84B | 14.91B |
| Cash Only | 16.99B | 25.11B | 34.76B | 22.12B | 13.18B | 23.24B | 19.68B | 10.03B | 8.94B | 11.74B | 9.36B | 18.84B | 8.37B |
| Short-Term Investments | 818.75M | 877.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.54B |
| Accounts Receivable | 25.88B | 29.4B | 23.13B | 16.42B | 20.23B | 19.88B | 14B | 11.14B | 9.66B | 9.33B | 9.59B | 12.12B | 9.58B |
| Days Sales Outstanding | 15.93 | 22.78 | 20.25 | 16.47 | 19.24 | 20.01 | 18.91 | 19.87 | 19.4 | 20.88 | 20.54 | 27.15 | 29.02 |
| Inventory | 44.52B | 43.63B | 41.02B | 32.99B | 37.85B | 33.95B | 22.7B | 17.35B | 14.5B | 12.45B | 12.28B | 13.98B | 9.84B |
| Days Inventory Outstanding | 30.72 | 38.77 | 42.27 | 37.14 | 42.78 | 42.15 | 36.83 | 36.69 | 34.08 | 32.6 | 30.07 | 36.37 | 35.29 |
| Other Current Assets | 2.62B | 2.38B | 7.11B | 7.08B | 8.12B | 6.85B | 4.15B | 3.41B | 3.8B | 2.58B | 2.69B | 4.86B | 3.03B |
| Total Non-Current Assets | 142.1B | 146.94B | 145.92B | 127.53B | 128.72B | 123.34B | 103.26B | 84.42B | 77.25B | 72.59B | 68.9B | 72.69B | 44.5B |
| Property, Plant & Equipment | 60.33B | 62.58B | 86.05B | 73.37B | 73.16B | 67.05B | 54.74B | 44.06B | 36.28B | 34.53B | 34.09B | 36.48B | 24.73B |
| Fixed Asset Turnover | 8.80x | 7.53x | 4.85x | 4.96x | 5.25x | 5.41x | 4.94x | 4.64x | 5.01x | 4.73x | 5.00x | 4.47x | 4.87x |
| Goodwill | 30.76B | 32.19B | 33.54B | 29.56B | 30.41B | 32.56B | 28.89B | 24.5B | 23.78B | 22.49B | 21.92B | 24.41B | 12.99B |
| Intangible Assets | 9.32B | 10.04B | 11.17B | 9.61B | 10.33B | 12B | 7.82B | 6.05B | 5.82B | 5.51B | 5.01B | 6.89B | 2.45B |
| Long-Term Investments | 53.51B | 26.13B | 237.24M | 274.02M | 294.84M | 243.19M | 171.1M | 93.63M | 84.97M | 64.01M | 362.63M | 354.13M | 295.35M |
| Other Non-Current Assets | 13B | 13B | 14.92B | 14.71B | 14.52B | 11.48B | 11.65B | 9.71B | 11.29B | 10B | 7.52B | 4.55B | 4.04B |
| Total Assets | 232.92B | 248.34B | 251.94B | 206.13B | 208.11B | 207.25B | 163.8B | 126.34B | 114.15B | 108.7B | 102.82B | 122.5B | 82.04B |
| Asset Turnover | 2.53x | 1.90x | 1.65x | 1.76x | 1.85x | 1.75x | 1.65x | 1.62x | 1.59x | 1.50x | 1.66x | 1.33x | 1.47x |
| Asset Growth % | -80.77% | -1.43% | 22.22% | -0.95% | 0.41% | 26.53% | 29.65% | 10.68% | 5.01% | 5.72% | -16.07% | 49.31% | - |
| Total Current Liabilities | 60.42B | 63.48B | 72.18B | 47.91B | 55.16B | 59.81B | 40.84B | 28.46B | 21.6B | 29.18B | 33.35B | 40.14B | 24.87B |
| Accounts Payable | 34.08B | 40.33B | 33.84B | 25.45B | 31.01B | 30.22B | 22.2B | 15.44B | 12.17B | 9.99B | 10.72B | 12.42B | 6.94B |
| Days Payables Outstanding | 24.86 | 35.83 | 34.88 | 28.66 | 35.05 | 37.51 | 36.01 | 32.65 | 28.58 | 26.17 | 26.24 | 32.31 | 24.89 |
| Short-Term Debt | 6.21B | 6.53B | 17.42B | 8.91B | 11.3B | 14.6B | 6.66B | 4.09B | 3.83B | 13.53B | 18.15B | 20.91B | 13.69B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 12.63B | 6.45B | 9.25B | 4.87B | 4.09B | 5.66B | 4.33B | 3.37B | 1.57B | 2.17B | 1.46B | 3.55B | 2.13B |
| Current Ratio | 1.50x | 1.60x | 1.47x | 1.64x | 1.44x | 1.40x | 1.48x | 1.47x | 1.71x | 1.24x | 1.02x | 1.24x | 1.51x |
| Quick Ratio | 0.77x | 0.91x | 0.90x | 0.95x | 0.75x | 0.84x | 0.93x | 0.86x | 1.04x | 0.81x | 0.65x | 0.89x | 1.11x |
| Cash Conversion Cycle | 21.78 | 25.72 | 27.64 | 24.95 | 26.97 | 24.65 | 19.73 | 23.91 | 24.89 | 27.32 | 24.37 | 31.22 | 39.41 |
| Total Non-Current Liabilities | 125.79B | 132.5B | 129.38B | 111.22B | 103.14B | 99.65B | 79.42B | 65.4B | 64.6B | 53.38B | 45.95B | 52.74B | 31.53B |
| Long-Term Debt | 105.81B | 111.41B | 106.77B | 92.51B | 84.13B | 80.6B | 61.34B | 50.95B | 53.23B | 43.5B | 38.11B | 44.98B | 26.39B |
| Capital Lease Obligations | 24.26B | 7.77B | 8.66B | 7.21B | 7.2B | 6.78B | 4.81B | 3.77B | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 19.64B | 6.43B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.49B | 6.89B | 13.95B | 11.51B | 11.82B | 12.26B | 13.27B | 10.68B | 11.37B | 9.88B | 7.84B | 7.77B | 5.14B |
| Total Liabilities | 186.21B | 195.97B | 201.57B | 159.13B | 158.3B | 159.45B | 120.26B | 93.86B | 86.2B | 82.56B | 79.3B | 92.88B | 56.4B |
| Total Debt | 119.33B | 125.71B | 134.93B | 110.33B | 104.41B | 103.61B | 74.11B | 59.75B | 57.06B | 57.02B | 56.26B | 65.88B | 40.08B |
| Net Debt | 102.35B | 100.6B | 100.17B | 88.2B | 91.23B | 80.37B | 54.43B | 49.72B | 48.13B | 45.28B | 46.9B | 47.04B | 31.71B |
| Debt / Equity | 2.55x | 2.40x | 2.68x | 2.35x | 2.10x | 2.17x | 1.70x | 1.84x | 2.04x | 2.18x | 2.39x | 2.22x | 1.56x |
| Debt / EBITDA | 3.62x | 3.57x | 4.03x | 7.85x | 2.95x | 2.43x | 2.76x | 3.22x | 4.78x | 5.10x | 5.09x | 5.15x | 3.73x |
| Net Debt / EBITDA | 3.11x | 2.85x | 2.99x | 6.27x | 2.58x | 1.88x | 2.03x | 2.68x | 4.03x | 4.05x | 4.24x | 3.68x | 2.95x |
| Interest Coverage | 2.87x | 2.46x | 15.60x | 3.44x | 19.28x | 34.51x | 5.65x | 3.24x | 2.01x | 1.49x | 2.12x | 3.71x | 2.99x |
| Total Equity | 46.71B | 52.37B | 50.37B | 47B | 49.81B | 47.8B | 43.54B | 32.48B | 27.95B | 26.14B | 23.52B | 29.62B | 25.64B |
| Equity Growth % | -79.86% | 3.97% | 7.17% | -5.64% | 4.21% | 9.77% | 34.06% | 16.23% | 6.91% | 11.16% | -20.61% | 15.52% | - |
| Book Value per Share | 43.34 | 49.01 | 22.71 | 21.19 | 22.09 | 19.28 | 16.40 | 12.18 | 10.48 | 9.19 | 8.60 | 10.22 | 8.90 |
| Total Shareholders' Equity | 42.44B | 47.87B | 44.78B | 43.35B | 46.34B | 44.12B | 40.12B | 29.64B | 25.65B | 24.29B | 22.37B | 28.03B | 23.87B |
| Common Stock | 202.63M | 171.18M | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 21.51B |
| Retained Earnings | 1.15B | 11.5B | 18.35B | 15.38B | 18.65B | 13.49B | 7.17B | 5.22B | 2.49B | 2.28B | 3.65B | 4.76B | 4.26B |
| Treasury Stock | -3.12B | -3.25B | 0 | 0 | 0 | -3.04B | -303.56M | -605.72M | -624.14M | 0 | -1.63B | -903.57M | -451.7M |
| Accumulated OCI | 44.65B | 39.44B | 2.65B | 4.18B | 3.9B | 9.88B | 9.47B | 1.23B | -10.39M | -1.78B | -3.44B | 387.79M | -1.66B |
| Minority Interest | 4.27B | 4.51B | 5.59B | 3.65B | 3.46B | 3.68B | 3.42B | 2.85B | 2.3B | 1.85B | 1.14B | 1.59B | 1.77B |
High leverage amid cyclicality
As reported in recent financial statements, JBS's total assets declined from $251.9B in 2024Q4 to $232.9B in 2026Q1, reflecting a contractionary trend that suggests the company's asset base is shrinking under the weight of persistent margin pressure and challenging global protein market conditions.
The reduction in total assets, coupled with a significant decline in retained earnings from $18.3B to $1.1B over the same period, indicates a rapid erosion of shareholder equity buffers. This trajectory warrants close monitoring as it suggests the company is struggling to maintain its scale while navigating a difficult phase of the livestock cycle.
Based on the provided balance sheet data, JBS maintains a Debt/Equity ratio of 2.55 as of 2026Q1, which represents a persistent reliance on external financing that appears increasingly precarious given the company's recent inability to generate consistent operating cash flow to service these obligations.
The high leverage ratio, which has remained consistently above 2.30 for the last ten quarters, suggests that JBS is structurally dependent on debt to fund its global operations and M&A strategy. Investors should consider that this level of indebtedness limits financial flexibility and increases sensitivity to interest rate volatility.
According to quarterly filings, JBS's cash position dropped sharply to $17.0B in 2026Q1 from a peak of $34.8B in 2024Q4, indicating that the company's liquidity buffer is being rapidly depleted to cover operational shortfalls and working capital requirements during this period of cyclical downturn.
While the current ratio of 1.50 remains technically adequate, the rapid decline in absolute cash levels suggests that the company's liquidity position is more fragile than headline ratios imply. This trend may indicate that the company is burning through its cash reserves to sustain operations, which could necessitate further financing if market conditions do not improve.
As disclosed in recent balance sheets, goodwill remains a substantial component of the asset base at $30.8B in 2026Q1, representing a significant portion of total equity that may be subject to impairment if the company's long-term earnings power continues to face downward pressure.
The reliance on goodwill, which stems from the company's aggressive acquisition history, creates a risk of non-cash write-downs that could further impair the balance sheet. The concentration of assets in PPE, which has also seen a decline, suggests that the company's ability to drive future growth through its existing physical footprint is currently constrained.
Quick answers to the most common questions about buying JBS stock.
As of 2025, JBS N.V. (JBS) had total assets of $248.34B including $101.40B in current assets.
JBS N.V. (JBS) carries total debt of $125.71B, offset by $25.98B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
JBS N.V. (JBS) has total shareholders' equity (book value) of $47.87B ($49.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.
JBS N.V. (JBS) reported a current ratio of 1.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.